Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?-Reference-Cited by-同舟云学术

Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?

Published:2019-02 Issue: Volume:58 Page:83-88
ISSN:1877-7821
Container-title:Cancer Epidemiology
language:en
Short-container-title:Cancer Epidemiology

Author:

Mazzone Elio^ORCID,Knipper Sophie,Mistretta Francesco A^ORCID,Tian Zhe,Preisser Felix^ORCID,Gallina Andrea^ORCID,Soulieres Denis,Tilki Derya,Montorsi Francesco,Shariat Shahrokh F.^ORCID,Saad Fred,Briganti Alberto,Wisnivesky Juan,Karakiewicz Pierre I.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Epidemiology

Reference20 articles.

1. 2017 EAU Muscle-invasive and Metastatic Bladder Cancer Guidelines;Witjes,2017

2. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J. Urol.,2017

3. Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology;Spiess;J. Natl. Compr. Cancer Netw.,2017

4. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder Cancer;Grossman;N. Engl. J. Med.,2003

5. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two nordic studies;Sherif;Eur. Urol.,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study;BMC Urology;2024-07-24

2. Patients With Muscle-Invasive Bladder Cancer With Lymphovascular Invasion in Transurethral Resection Specimen Benefits Most From Platinum-Based Neoadjuvant Chemotherapy;Clinical Genitourinary Cancer;2023-11

3. Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis;Urologic Oncology: Seminars and Original Investigations;2023-03

4. Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study;BMC Cancer;2022-12-12

5. The impact of non-modifiable sociodemographic factors on bladder cancer survival outcomes after radical cystectomy: A systematic review and cumulative analysis of population cohort studies;Frontiers in Urology;2022-09-13